Real-world Patient Use and Perception, Satisfaction, and Adherence with a Calcipotriol and Betamethasone Dipropionate PAD-cream for the Treatment of Plaque Psoriasis

Main Article Content

José Luis López Estebaranz
Hjalmar Kurzen
Marta Menendez
Giulia Greta Dradi
Jordi Galvan

Keywords

psoriasis, cream, cal/bdp, real-world

Abstract

            


 

References

1. Pinter A, et al. J Eur Acad Dermatol Venereol. 2023;37 Suppl 1:3–8.

2. Torres T, et al. Dermatol Ther (Heidelb). 2023;13(10):2153–69.

Article Sidebar

PDF
Published
Nov 18, 2024
DOI https://doi.org/10.25251/skin.8.supp.424

Article Details

How to Cite
[1]
Estebaranz, J.L.L., Kurzen, H. , Menendez, M., Dradi, G.G. and Galvan, J. 2024. Real-world Patient Use and Perception, Satisfaction, and Adherence with a Calcipotriol and Betamethasone Dipropionate PAD-cream for the Treatment of Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s424. DOI:https://doi.org/10.25251/skin.8.supp.424.
Issue
Vol. 8 No. 6 (2024): November 2024 Issue
Section
Poster Presentations from FC24 Dermatology Conference®: Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.